Genocea Breaks Out With Very Positive Mid-Stage Results
Genocea Biosciences soared early on Thursday, following the release of positive data from its mid-stage genital herpes clinical trial.
All Work
Chris Lange
United Guaranty Files for IPO
United Guaranty has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Micron Posts Q2 Bottom Line Beat
Micron Technology, Inc. (NASDAQ: MU) reported its fiscal second quarter financial results after the markets closed on Wednesday. The company had a net loss of $0.05 per share on $2.93 billion in revenue compared…
What to Look for in Voxeljet Earnings
Voxeljet AG (NYSE: VJET) is set to report its fiscal fourth-quarter financial results after the markets close on Thursday. The consensus estimates from Thomson Reuters are calling for a net loss of $0.12 per…
SEC Settles Charges With Venture Capitalist Over Stolen Investor Funds
The SEC has announced that a San Francisco-based biotech venture capitalist will settle charges that he siphoned money from a fund managed by his firm in order to prop up other struggling businesses he…
What Disney May Have in Store With Its Newest Lego Deal
Lego has announced its 18th collection of LEGO Minifigures, starring some of Disney's most beloved characters.
Opko Health Stumbles Over FDA Letter
Opko Health saw its shares slide in Wednesday’s regular trading session following the release of a complete response letter from the FDA.
ContraVir Pharma Falls on Secondary Offering Pricing
ContraVir Pharmaceuticals stock shot up following positive results from a hepatitis B study earlier this week, but now it is back down after the pricing of a secondary offering was announced.
What to Expect From Micron Earnings
Micron Technology is scheduled to report its fiscal second-quarter financial results after the markets close on Wednesday.
Verint Systems Sinks on Missed Earnings
Verint Systems reported disappointing fiscal fourth-quarter financial results after the markets closed on Tuesday.
Acadia Posts Big Win With FDA Approval
Acadia Pharmaceuticals saw its shares on the rise again this week following an incredibly positive FDA vote on its Parkinson's treatment.
SEC Settles Penny Stock Fraud Charges With Former TV Commentator
The SEC has announced that a former market analyst and TV news commentator has agreed to settle charges that he and his company fraudulently promoted a penny stock to investors.
What to Expect From Lululemon Earnings
Lululemon Athletica is scheduled to report its fiscal fourth-quarter financial results before the markets open on Wednesday.
SEC Charges Aveo With Misleading Investors
The SEC has announced fraud charges against Aveo Pharmaceuticals and three former executives for misleading investors.
SEC Charges Securities Professional With Defrauding Institutional Investors
The SEC has charged a New York-based securities professional with defrauding two institutions he solicited to invest in a shell company he controlled.
ContraVir Pharma Takes Off on Positive Results
ContraVir Pharmaceuticals led the bulls early on Tuesday following the release of positive hepatitis B results.
BioPharmX Prices Secondary Offering
BioPharmX saw its shares take a sharp downward turn following the announcement of a secondary offering.
Inovio Fails to Impress With HPV Business Update
Inovio Pharmaceuticals made waves early on Tuesday morning following an update for its human papillomavirus (HPV) treatment.
Conn’s Disappoints on Bottom Line, Names New Chairman
Conn's reported mixed fiscal fourth-quarter financial results before the markets opened on Tuesday.
8 Major Biopharma Events Coming Later in 2016 and in 2017
FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in 2016 or 2017.